1、White PaperCreating a Motivating Engagement Ecosystem:Achieving Success in Obesity ResearchDEBRA GERLACH,Director,Patient Recruitment Strategy Clinical Operations,IQVIASTEPHANIE GALARZA,Associate Director,Patient Recruitment Strategy Clinical Operations,IQVIAIncorporating the patient voice and lived

2、 experience into the trial journeyTable of contentsUnderstanding the emotional impact of obesity 1Insight-driven strategies for a supportive treatment experience 3Customizing engagement for diverse patient populations 4Elevating the patient voice in trial content 6Designing engagement strategy aroun

3、d the patients lived experience 6Personalizing nutritional counseling with registered dietitians 7What sites need:Strategies and tools for optimal support 8Beyond Borders:Leveraging site intelligence for regional customization 9Looking ahead:Opportunities and challenges in obesity research 10Referen

4、ces 11About the authors 12 |1Understanding the emotional impact of obesityThe development,widespread adoption,and intense public curiosity of GLP-1 receptor agonists have reshaped global perceptions of obesity and transformed therapeutic approaches.These innovations have sparked robust dialogue acro

5、ss clinical,cultural,and societal domains,lending legitimacy to the recognition of obesity as a treatable medical condition.The surge of more than 124 investigational molecules in the pipeline presents a significant opportunity to improve the health of millions of people struggling with obesity worl

6、dwide.This growth will intensify competition among sponsors,CROs,and sites for participant recruitment and retention.As more approved treatment options become available,finding treatment-nave patients will become increasingly challenging.Additionally,since many of these pipeline candidates target pa